Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Delisting risk
confidence 95%
filed 2026-05-22
The filing discloses a delinquency compliance alert from Nasdaq on May 21, 2026, advising that Global Interactive Technologies is not in compliance with Nasdaq Listing Rule 5250(c)(1) due to failure to timely file its Form 10-Q for Q1 2026 and its Form 10-K for 2025. The company has until October 12, 2026 to regain compliance, with a required update to its compliance plan by June 22, 2026. This is a classic delisting risk disclosure under Item 3.01.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-05-22
The filing discloses multiple material transactions on May 21, 2026: (1) issuance of convertible notes totaling $970,600 principal ($807,100 net proceeds) to CFI Capital and Monroe Street Capital with conversion rights at 80% of VWAP, reserving 2,206,434 shares; (2) a Services Agreement with Mammoth Crest Capital granting 4.5% equity stake plus $500,000 in cash fees; and (3) a Side Letter requiring shareholder approval for issuances exceeding the 19.99% Exchange Cap. These unregistered equity issuances under Section 4(a)(2) are highly dilutive and material to investors assessing ownership and capital structure.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-05-22
The filing discloses issuance of 535,000,000 shares of common stock to officers, directors, and consultants pursuant to the 2026 Equity Incentive Plan and an effective Form S-8 registration statement. This represents a massive dilutive equity issuance that would materially affect shareholder ownership and is a strong signal of capital structure change typical of small-cap companies raising resources or compensating insiders.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-05-22
Item 2.02
The filing discloses BJ's Wholesale Club's financial results for the first quarter of fiscal year 2026 ended May 2, 2026, via a press release furnished as Exhibit 99.1. This is a standard quarterly earnings release disclosure under Item 2.02, which is material to investors as it provides periodic financial performance information.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-05-22
Item 5.02
The disclosure centers on the compensation committee's grant of stock options to named executive officers (Wade Black, CFO, and Phillip Nickerson, VP of Exploration) under the 2022 long-term incentive plan. The specific terms—exercise price, vesting schedule, and number of shares—are classic equity compensation arrangements that materially affect executive remuneration and would influence investor assessment of management incentives.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-22
Item 5.07
This is a clear disclosure of shareholder voting results from the May 21, 2026 Annual Meeting of Stockholders, filed under Item 5.07. The filing reports final vote tallies for four proposals: election of two Class II directors (Sara Baack and Ligia Torres Fentanes), approval of amendments to the 2006 Stock Incentive Plan, advisory approval of executive compensation, and ratification of KPMG LLP as independent auditor. All proposals passed with substantial majorities, making this a routine but material annual meeting disclosure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-22
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of Eve Holding's 2026 Annual Meeting of Stockholders held on May 21, 2026. The filing presents voting results for four proposals: election of Class I directors (Sergio Pedreiro and Uallace Moreira Lima), advisory approval of NEO compensation, frequency of future advisory votes on compensation (approved for every three years), and ratification of KPMG LLP as independent auditor. All proposals passed with substantial majorities, making this a routine but material shareholder vote results disclosure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-22
Item 5.07
Zoetis held its Annual Meeting of Shareholders on May 20, 2026, with voting results on five proposals: election of twelve directors, advisory votes on executive compensation and frequency thereof, ratification of KPMG LLP as independent auditor, and a shareholder proposal on written consent.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-05-22
Item 2.01
AH Realty Trust completed the disposition of nine multifamily properties for approximately $485.0 million in aggregate proceeds on May 20, 2026, as the first closing under a larger $562.0 million multifamily disposition agreement entered into on March 13, 2026. Two additional properties are expected to close by mid-2027.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-05-22
Item 1.01
The filing discloses Amendment No. 3 to the Fifth Amended and Restated Advisory Agreement between Braemar Hotels and its advisor Ashford Inc., extending the negotiation period for revised Base Fee and Incentive Fee terms through December 31, 2026. While this is a material definitive agreement amendment affecting the company's advisory fee structure, it does not fit cleanly into the more specific event categories (not M&A, not exec compensation, not a routine administrative change). The amendment's materiality lies in its potential impact on the company's operating costs and advisor relationship, warranting disclosure as a material event.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-22
Item 5.07
Wayfair held its Annual Meeting of stockholders and disclosed certified vote results on four proposals: election of nine directors, ratification of PricewaterhouseCoopers LLP as independent auditor, non-binding advisory approval of named executive officer compensation, and approval of Amendment No. 1 to the 2023 Incentive Award Plan increasing authorized shares by 20,000,000 for equity compensation purposes.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-05-22
Item 2.02
Booz Allen Hamilton disclosed results of operations for the fiscal year ended March 31, 2026, via a press release (Exhibit 99.1) and posted an earnings conference call presentation to its investor relations website (Exhibit 99.2) on May 22, 2026.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-22
The filing discloses Item 5.07 results from Bunge Global SA's 2026 Annual General Meeting of Shareholders held on May 20, 2026, with detailed vote tabulations on 12 matters including approval of financial statements, director elections, board chair reelection, compensation approvals, and auditor appointment. This is a standard shareholder vote results disclosure that is material to investors as it confirms governance actions and executive compensation approvals.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-22
Item 5.07
This is a clear disclosure of shareholder vote results from the Company's Annual Meeting held on May 19, 2026. The filing reports voting outcomes on three proposals: election of directors (Patrick M. Covey, Jerome P. Grisko Jr., and Thomas A. Haught), advisory approval of named executive officer compensation, and ratification of Deloitte & Touche LLP as independent auditor. Item 5.07 is the designated 8-K item for shareholder vote results, and the prose directly presents vote tallies for each proposal.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-22
Item 5.07
This is a clear disclosure of shareholder vote results from the 2026 Annual Meeting held on May 21, 2026, covering three matters: election of four directors, advisory vote on named executive officer compensation, and ratification of KPMG LLP as independent auditor. The filing presents detailed vote tallies for each matter, which is the core content of Item 5.07 disclosures and materially informs investors of governance outcomes.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-05-22
Item 2.02
Cavco Industries disclosed financial results for fiscal fourth quarter and full year ended March 28, 2026, with a press release attached as Exhibit 99.1.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-05-22
Item 8.01
The Board approved a $150 million stock repurchase program on May 18, 2026, representing a material capital allocation decision affecting shareholder value and the company's financial flexibility.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 80%
filed 2026-05-22
Item 3.02
Ares Real Estate Income Trust amended its subscription agreement with Apogee SPV, an affiliate of the Company's advisor, whereby Apogee will purchase an additional $100 million in Class B Common Shares, bringing the total commitment to $300 million. This unregistered equity issuance represents a material capital transaction affecting the Company's capitalization and ownership structure.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 85%
filed 2026-05-22
Item 5.02
The disclosure under Item 5.02(e) describes amendments to employment agreements for six executive officers (Bordelon, Guidry, Herpin, Kirkley, Lemoine, and Zollinger) that extend the terms of their existing agreements to 2028–2029. While the filing states "no other changes were made," the extension of employment agreements constitutes a material compensatory arrangement modification affecting named executives. This falls squarely within the exec_compensation category as a material arrangement affecting executive tenure and job security.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-05-22
Item 1.01
BlackSky entered into a Sales Agreement with Deutsche Bank Securities and Craig-Hallum Capital Group to offer and sell up to $250 million of Class A common stock through an "at the market offering" under Rule 415(a)(4). This is a classic ATM offering—a dilutive equity issuance that allows the company to raise capital by selling shares at market prices over time. The magnitude ($250M) and structure (registered direct offering through sales agents) are material to investors assessing shareholder dilution and the company's capital-raising strategy.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-05-22
Item 3.02
Ares Sports, Media & Entertainment Opportunities LP completed an unregistered private placement of approximately $27.5 million in limited partnership units to accredited investors and qualified purchasers under Section 4(a)(2) and Regulation D, bringing cumulative issuances to approximately $769 million.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-22
Item 5.07
Stockholders voted at the Annual Meeting held on May 21, 2026, approving the election of nine directors, advisory approval of named executive officer compensation, an amendment to the 2023 Equity Incentive Plan increasing authorized shares by 5,000,000 shares, and ratification of Deloitte & Touche LLP as independent auditor.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-05-22
Item 8.01
Merck closed a $5.5 billion underwritten public offering of debt securities across seven tranches (Floating Rate Notes, 2028, 2031, 2033, 2036, 2046, and 2056 Notes). While this is a material financing event affecting the company's capital structure and liquidity, it does not fit neatly into the specific taxonomy categories (not M&A, not a dilutive equity issuance, not a restatement or covenant breach). This is a significant debt issuance that would materially affect a reasonable investor's assessment of the registrant's financial position and leverage.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-05-22
Item 5.02
Jared Chomko was appointed as Principal Accounting Officer effective May 19, 2026, filling a position that had been vacant and filled on an interim basis by the CFO since October 2025. This appointment represents a material change in the company's financial reporting infrastructure and accounting leadership.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-22
Item 5.07
At Ibotta's May 19, 2026 annual meeting of shareholders, four proposals were submitted to a vote and all passed with substantial majorities: election of Class II directors Amit Doshi and Larry Sonsini, advisory approval of named executive officer compensation, annual frequency of say-on-pay votes, and ratification of KPMG as independent auditor.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 95%
filed 2026-05-22
Item 3.01
RCI Hospitality received a written notice from Nasdaq on May 20, 2026 indicating non-compliance with Listing Rule 5250(c)(1) due to failure to file the Form 10-Q for Q1 2026. The company has until July 20, 2026 to submit a compliance plan and until November 16, 2026 to regain compliance by filing the overdue Form 10-Q. This is a classic delisting risk disclosure under Item 3.01, as it notifies investors of a failure to satisfy continued listing standards and the potential consequences if compliance is not restored.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-22
Item 5.07
Everspin held its Annual Meeting of Stockholders on May 21, 2026, with stockholders voting on four proposals: election of seven directors, ratification of Ernst & Young LLP as independent auditor, advisory approval of named executive officer compensation, and approval of an amended equity incentive plan. The filing discloses complete tabulated vote results for each proposal.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 92%
filed 2026-05-22
Item 5.02
Stockholders approved an amended and restated equity incentive plan that materially expands the share reserve by 1,800,000 shares and modifies the terms governing stock option and equity awards to directors and officers. This material amendment to the equity compensation plan was approved at the May 21, 2026 Annual Meeting.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-22
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of Ring Energy's 2026 annual stockholder meeting held on May 21, 2026. The filing presents voting outcomes for three proposals: election of seven directors (all duly elected), advisory approval of executive compensation, and ratification of Grant Thornton LLP as independent auditor. These are routine but material governance matters that affect investor understanding of board composition and corporate oversight.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-22
Item 5.07
Lazard held its Annual Meeting of Stockholders on May 21, 2026, with final voting results disclosed for five proposals: election of three directors (Orszag, Jarrard, Knobloch), a non-binding advisory vote on executive compensation, approval of a Certificate of Incorporation amendment to declassify the Board, approval of an amendment to the 2018 Incentive Compensation Plan, and ratification of Deloitte & Touche LLP as independent auditor.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-22
Item 5.07
Wingstop disclosed the complete results of its 2026 Annual Meeting of Stockholders held on May 21, 2026, including voting outcomes for director elections, auditor ratification, executive compensation advisory vote, and bylaw amendments.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-22
Item 5.07
This Item 5.07 disclosure presents the complete voting results from FB Financial Corporation's annual meeting of shareholders held on May 21, 2026, including election of 13 directors, approval of the 2026 Incentive Plan, approval of stock purchase plan amendments, advisory vote on named executive officer compensation, charter amendment proposal (which failed), and ratification of Crowe LLP as independent auditor. The detailed tabular voting results for each proposal are the hallmark of shareholder vote results disclosure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-22
Item 5.07
This is a clear disclosure of shareholder vote results from Community Bancorp's Annual Meeting of Shareholders held on May 19, 2026. The filing reports voting outcomes for two proposals: election of two directors (Emma L. Marvin and Jacques R. Couture) and ratification of BDMP Assurance, LLP as external auditors. The detailed vote tallies and confirmation that both proposals passed are the core content of Item 5.07, which is the standard Item for reporting shareholder meeting results.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-05-22
Item 7.01
The CEO's remarks disclose material information about the company's liquidity strategy and portfolio performance, including a decline in net asset value from $0.27 to $0.29 per share driven by Denver multifamily market softness, and acknowledgment that "uncertainty around the terms, timing, and completion risk for one material transaction in our non-core portfolio delayed our ability to deliver a liquidity event." While the disclosure centers on forward-looking plans for a potential liquidity event rather than a completed transaction or specific executive action, the material transaction delays and NAV decline would affect a reasonable investor's assessment of the REIT's near-term prospects and shareholder value realization.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-05-22
Item 5.03
iPower Inc. implemented a 1-for-8 reverse stock split of its common stock, approved by stockholders on December 21, 2025, and effective May 22, 2026. The reverse split affects share count, per-share metrics, and trading mechanics on Nasdaq, and was announced on May 19, 2026.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-22
Item 5.07
This Item 5.07 disclosure reports the final voting results from Actuate Therapeutics' May 21, 2026 Annual Meeting of Stockholders, including the election of two Class II directors (Aaron G.L. Fletcher and Jason Keyes) and ratification of Crowe LLP as independent auditor. The tabulated vote counts for each proposal are the core content, matching the shareholder_vote_results taxonomy precisely.
View raw filing on EDGAR →
8-K
Exec departure
confidence 92%
filed 2026-05-22
Item 5.02
Michelle Burke resigned as Co-Chief Executive Officer and director of Z Squared Inc. effective May 22, 2026. While the filing also discloses that David Halabu continues as sole CEO, the principal disclosed action is Ms. Burke's departure from executive and board roles. The resignation is material as it represents a change in senior leadership at a company that recently completed a business combination (April 24, 2026).
View raw filing on EDGAR →
8-K
M&A activity
confidence 75%
filed 2026-05-22
Item 1.01
The filing discloses entry into a material definitive agreement—a $5.0 million revolving credit facility with nFusion Capital Finance, LLC. While this is a financing arrangement rather than a traditional M&A transaction, Item 1.01 is the appropriate disclosure vehicle for material definitive agreements. The secured credit facility with customary covenants, collateral requirements, and fees is material to the registrant's capital structure and liquidity position. However, the event is classified as ma_activity (the closest fit for material agreements affecting the registrant's financial position) rather than a more specific category, as the taxonomy lacks a dedicated financing event type.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-22
Item 5.07
This is a clear disclosure of shareholder voting results from the Company's Annual Meeting of Shareholders held on May 22, 2026, covering three proposals: election of directors, advisory vote on named executive officer compensation, and ratification of the independent auditor. Item 5.07 explicitly requires disclosure of shareholder vote results, and the filing presents the voting tallies for each proposal with vote counts for, against, abstain, and broker non-votes.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-22
Item 5.07
This is a clear Item 5.07 disclosure of shareholder vote results from Dianthus Therapeutics' Annual Meeting of Stockholders held on May 21, 2026. The filing presents final voting tallies for three proposals: election of Class II directors (Sujay Kango, Anne McGeorge, and Jonathan Violin, Ph.D.), advisory approval of executive compensation, and ratification of Deloitte & Touche, LLP as independent auditor. All three proposals passed with substantial majorities, making this a material governance event that affects investor understanding of board composition and shareholder sentiment.
View raw filing on EDGAR →
8-K
Earnings release
confidence 85%
filed 2026-05-22
Item 8.01
The filing discloses a press release announcing net asset value (NAV) for the quarter ended March 31, 2026. For a closed-end investment company like Equus Total Return, Inc., quarterly NAV disclosure is a standard financial results announcement analogous to earnings releases for operating companies. This is material information that investors rely on to assess fund performance and value.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-05-22
Item 3.02
The filing discloses multiple unregistered equity issuances totaling approximately $3.8 million in Class E and Class I common shares issued on May 1 and May 20, 2026, pursuant to Section 4(a)(2) of the Securities Act. These include management fee payments to the Adviser (105,468 Class I shares), distribution reinvestment plan issuances to Brookfield affiliates (161,445 Class I shares and 91,337 Class E shares), and employee share sales (67,566 Class E shares). The cumulative dilutive effect and related-party nature of these transactions make this a material dilutive issuance event.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-05-22
Item 7.01
The disclosure announces topline results from a Phase 2b clinical trial (LUMA study) for BIIB122 (DNL151), a Parkinson's disease candidate co-developed with Biogen. While clinical trial results are material to investors evaluating the company's pipeline and prospects, this does not fit neatly into the standard taxonomy categories (not an earnings release, M&A activity, or other enumerated event types). The Regulation FD disclosure format and emphasis on trial outcomes support classification as a material event outside the specific categories.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 94%
filed 2026-05-22
Item 3.01
Anavex received a delinquency notification from Nasdaq on May 20, 2026, for failure to timely file its Form 10-Q, triggering non-compliance with Nasdaq Listing Rule 5250(c)(1). The company has until July 20, 2026, to submit a compliance plan and until November 16, 2026, to regain compliance, or face potential delisting proceedings.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-05-22
Item 5.03
Sadot Group Inc. approved and filed a 1-for-20 reverse stock split, effective May 27, 2026, explicitly intended to raise the per-share bid price above $1.00 to comply with Nasdaq Listing Rule 5550(a)(2) and address delisting risk. The amendment was disclosed via press release on May 22, 2026.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-22
Item 5.07
This Item 5.07 discloses the results of Privia Health Group's 2026 Annual Meeting of Stockholders held on May 20, 2026, with detailed voting tallies for three proposals: election of three Class I directors (Nancy Cocozza, David King, and Francis Soistman), advisory approval of named executive officer compensation, and ratification of PricewaterhouseCoopers LLP as independent auditor. All three proposals were approved by stockholders, making this a clear shareholder vote results disclosure.
View raw filing on EDGAR →
8-K
Exec departure
confidence 75%
filed 2026-05-22
Item 5.02
Jason Pello's departure as Chief Financial Officer effective April 3, 2026 is the principal disclosed action. While the filing also documents compensatory arrangements (consulting payments of $223,125 and continued vesting of RSUs), the core event is the CFO's separation from the Company. The departure of a named executive officer in a C-suite role is material to investors assessing management continuity and financial oversight.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-22
Item 5.07
This Item 5.07 disclosure reports the final results of Sotera Health's 2026 annual meeting of stockholders held on May 21, 2026, including voting outcomes on three matters: election of four Class III directors, advisory approval of named executive officer compensation, and ratification of Ernst & Young LLP as independent auditor. The detailed vote tallies (For/Against/Withheld/Abstain/Broker Non-Votes) for each proposal are the core content, making this a textbook shareholder vote results disclosure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-22
Item 5.07
This is a clear disclosure of shareholder voting results from Amalgamated Financial Corp.'s Annual Meeting of Stockholders held on May 20, 2026. The filing presents detailed vote tallies for three proposals: election of 13 directors, advisory approval of named executive officer compensation, and ratification of the independent auditor (Crowe LLP). This is the quintessential Item 5.07 disclosure and is material to investors as it documents the outcomes of fundamental corporate governance matters.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-05-22
This 8-K discloses the completion of Berto Acquisition Corp. II's initial public offering (IPO) on May 18, 2026, raising $315.1 million in gross proceeds from the sale of 31.51 million units, plus a concurrent private placement of 3.5 million warrants for $3.5 million. While IPO completion is a material capital-raising event affecting the registrant's financial position and investor base, it does not fit neatly into the standard taxonomy categories (earnings_release, ma_activity, dilutive_issuance, etc.). The disclosure is material to investors as it establishes the company's public status and capital structure, but the event itself—an IPO completion—is best classified as other_material.
View raw filing on EDGAR →